Structural Immunology Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6223-8. doi: 10.1073/pnas.1100622108. Epub 2011 Mar 28.
Natural killer (NK) cells are a group of innate immune cells that carry out continuous surveillance for the presence of virally infected or cancerous cells. The natural cytotoxicity receptor (NCR) NKp30 is critical for the elimination of a large group of tumor cell types. Although several ligands have been proposed for NKp30, the lack of a conserved structural feature among these ligands and their uncertain physiological relevance has contributed to confusion in the field and hampered a full understanding of the receptor. To gain insights into NKp30 ligand recognition, we have determined the crystal structure of the extracellular domain of human NKp30. The structure displays an I-type Ig-like fold structurally distinct from the other natural cytotoxicity receptors NKp44 and NKp46. Using cytolytic killing assays against a range of tumor cell lines and subsequent peptide epitope mapping of a NKp30 blocking antibody, we have identified a critical ligand binding region on NKp30 involving its F strand. Using different solution binding studies, we show that the N-terminal domain of B7-H6 is sufficient for NKp30 recognition. Mutations on NKp30 further confirm that residues in the vicinity of the F strand, including part of the C strand and the CD loop, affect binding to B7-H6. The structural comparison of NKp30 with CD28 family receptor and ligand complexes also supports the identified ligand binding site. This study provides insights into NKp30 ligand recognition and a framework for a potential family of unidentified ligands.
自然杀伤 (NK) 细胞是一组先天免疫细胞,它们对病毒感染或癌细胞的存在进行持续监测。自然细胞毒性受体 (NCR) NKp30 对于消除一大类肿瘤细胞类型至关重要。尽管已经提出了几种 NKp30 的配体,但这些配体缺乏保守的结构特征及其不确定的生理相关性,导致该领域存在混淆,并阻碍了对该受体的全面理解。为了深入了解 NKp30 配体识别,我们已经确定了人 NKp30 细胞外结构域的晶体结构。该结构显示出 I 型 Ig 样折叠,与其他自然细胞毒性受体 NKp44 和 NKp46 在结构上不同。通过针对一系列肿瘤细胞系的细胞溶解杀伤测定以及随后对 NKp30 阻断抗体的肽表位作图,我们确定了 NKp30 上涉及 F 链的关键配体结合区域。使用不同的溶液结合研究,我们表明 B7-H6 的 N 端结构域足以被 NKp30 识别。NKp30 的突变进一步证实,F 链附近的残基,包括 C 链和 CD 环的一部分,影响与 B7-H6 的结合。NKp30 与 CD28 家族受体和配体复合物的结构比较也支持鉴定的配体结合位点。这项研究提供了对 NKp30 配体识别的深入了解,并为潜在的未识别配体家族提供了框架。